Pooneh Pordeli
Mississauga, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis.
Journal: Clinical and translational science
Published: May 17, 2022
Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis.
Journal: Rheumatology and therapy
Published: December 14, 2021
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Journal: The New England journal of medicine
Published: June 07, 2021
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 03, 2020
Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis.
Journal: Arthritis care & research
Published: November 20, 2019
Time for a Time Window Extension: Insights from Late Presenters in the ESCAPE Trial.
Journal: AJNR. American journal of neuroradiology
Published: April 17, 2017
Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage After Intravenous Alteplase Therapy.
Journal: Stroke
Published: January 09, 2017
Regional Comparison of Multiphase Computed Tomographic Angiography and Computed Tomographic Perfusion for Prediction of Tissue Fate in Ischemic Stroke.
Journal: Stroke
Published: November 08, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026